Floatz logo

FLUOROURACILUM

Brain Injury

Hennepin Healthcare Research InstituteSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Brain Injury cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
Calcium folinate pentahydrate
Hennepin Healthcare Research Institute
Phase 4BB
CIS-DIAMMINEDICHLOROPLATINUM II
Hennepin Healthcare Research Institute
Phase 4BB
Enoxaparin
Hennepin Healthcare Research Institute
Phase 4BB
Botulinum Toxin Type B
Georgetown University
Phase 4B

View all 20 →

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →